“My patients respond to the Anticancer Lifestyle Program in a way I find unprecedented in 30 years of Radiation Oncology practice. It helps them feel that we are caring for them, and not just delivering cancer treatment.”

I am so glad I found the AntiCancer Lifestyle Program. This is an amazing idea and gift. Our son-in-law at 39 has glioblastoma. After surgery, chemo, and radiation we hope, no relapse. Hope, however, is not a plan. My wife and I are changing to help him change.”

Cancer survivor Steve Mosher Talks About the Anticancer Fitness.



View All Testimonials

Estrogen Disrupting Chemicals (EDCs) found to impact erectile funtion

A study published in Communications Biology found that EDCs promoted erectile dysfunction in mice:

Erectile dysfunction (ED) is an extremely prevalent condition which significantly impacts quality of life. The rapid increase of ED in recent decades suggests the existence of unidentified environmental risk factors contributing to this condition. Endocrine Disrupting Chemicals (EDCs) are one likely candidate, given that development and function of the erectile tissues are hormonally dependent. We use the estrogenic-EDC diethylstilbestrol (DES) to model how widespread estrogenic-EDC exposure may impact erectile function in humans. Here we show that male mice chronically exposed to DES exhibit abnormal contractility of the erectile tissue, indicative of ED. The treatment did not affect systemic testosterone production yet significantly increased estrogen receptor α (Esr1) expression in the primary erectile tissue, suggesting EDCs directly impact erectile function.